Erin Bugenske Stallings

Erin Bugenske Stallings

Auto-generated profile, based on publicly available information

Erin Bugenske Stallings

National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2019 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
ESErin B. Stallings
Erin B. Stallings
JIJennifer L. Isenburg
Jennifer L. Isenburg
TSTyiesha D. Short
Tyiesha D. Short
DHDominique Heinke
Dominique Heinke
Russell S. KirbyRussell S. Kirby
Russell S. Kirby
Philip LupoPhilip Lupo
Philip Lupo

1 June 2012 in Pediatrics
Verified
Journal Article
Closed access
PDF file
EBErin Bugenske
Erin Bugenske
SSShannon Stokley
Shannon Stokley
AKAllison Kennedy
Allison Kennedy
CDChristina Dorell
Christina Dorell
OBJECTIVE: To determine if middle school vaccination requirements are associated with higher coverage for adolescent vaccines.METHODS: School entry requirements for receipt of vaccination for school entry or education of parents for 3 vaccines recommended for adolescents: tetanus/diphtheria-containing (Td) or tetanus/diphtheria/acellular pertussis (TdaP), meningococcal conjugate (MenACWY), and human papillomavirus (HPV) vaccines in place for the 2008–2009 school year were reviewed for the 50 states and the District of Columbia. Vaccination coverage levels for adolescents 13 to 17 years of age by state requirement status and change in coverage from 2008 to 2009 were assessed by using the 2008–2009 National Immunization Survey-Teen.RESULTS: For the 2008–2009 school year, 32 states had requirements for Td/TdaP (14 specifically requiring TdaP) and none required education; 3 states required MenACWY vaccine and 10 others required education; and 1 state required HPV vaccine and 5 required education. Compared with states with no requirements, vaccination requirements were associated with significantly higher coverage for MenACWY (71% vs 53%, P < .001) and Td/TdaP (80% vs 70%, P < .001) vaccines. No association was found between education-only requirements and coverage levels for MenACWY and HPV vaccines. States with new 2008–2009 vaccination requirements (n = 6, P = .04) and states with preexisting vaccination requirements (n = 26, P = .02) for Td/TdaP experienced a significant increase in TdaP coverage over states with no requirements.CONCLUSIONS: Middle school vaccination requirements are associated with higher coverage for Td/TdaP and MenACWY vaccines, whereas education-only requirements do not appear to increase coverage levels for MenACWY or HPV vaccines. The impact on coverage should continue to be monitored as more states adopt requirements.

19 January 2022 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
ESErin Bugenske Stallings
Erin Bugenske Stallings
JIJennifer L. Isenburg
Jennifer L. Isenburg
DADeepa Aggarwal
Deepa Aggarwal
Philip LupoPhilip Lupo
Philip Lupo
MOMatthew E. Oster
Matthew E. Oster
FNFor The National Birth Defects Prevention Network
For The National Birth Defects Prevention Network

15 November 2018 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
ESErin B. Stallings
Erin B. Stallings
JIJennifer L. Isenburg
Jennifer L. Isenburg
CMCara T. Mai
Cara T. Mai
RLRebecca F. Liberman
Rebecca F. Liberman
CMCynthia A. Moore
Cynthia A. Moore
FNFor The National Birth Defects Prevention Network
For The National Birth Defects Prevention Network

19 November 2022 in Birth Defects Research
Verified
Journal Article
Open access
VKVijaya Kancherla
Vijaya Kancherla
MSManasvi Sundar
Manasvi Sundar
LTLucita Tandaki
Lucita Tandaki
ALAnke Lux
Anke Lux
MBMarian K Bakker
Marian K Bakker
ARAnke Rissmann
Anke Rissmann
Purpose: We examined the total prevalence, trends in prevalence, and age‐specific mortality among individuals with anorectal malformation (ARM)Methods: We conducted a retrospective cohort study using data from 24 population‐ and hospital‐based birth defects surveillance programs affiliated with the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) from 18 countries and for births from 1974 to 2014. We estimated pooled and program‐specific total prevalence per 10,000 total births. Poisson regression was used to assess time trends in prevalence from 2001 to 2012 when most programs contributed data. We calculated selected age‐specific proportions of deaths, stratified by case statusResults: The pooled total prevalence of ARM was 3.26 per 10,000 total births (95% Confidence Interval = 3.19, 3.32) for birth years 1974–2014. About 60% of cases were multiple or syndromic. Prevalence of multiple, syndromic, and stillborn cases decreased from 2001 to 2012. The first week mortality proportion was 12.5%, 3.2%, 28.3%, and 18.2% among all, isolated, multiple, and syndromic cases, respectivelyConclusions: ARM is relatively rare, with multiple and syndromic cases showing decreasing prevalence during the study period. Mortality is a concern during the first week of life, and especially among multiple and syndromic cases. Our descriptive epidemiological findings increase our understanding of geographic variation in the prevalence of ARM and can be used to plan needed clinical services. Exploring factors influencing prevalence and mortality among individuals with ARM could inform future studies.

21 December 2020 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
DHDominique Heinke
Dominique Heinke
JIJennifer L. Isenburg
Jennifer L. Isenburg
ESErin B. Stallings
Erin B. Stallings
TSTyiesha D. Short
Tyiesha D. Short
MLMimi Le
Mimi Le
FNFor The National Birth Defects Prevention Network
For The National Birth Defects Prevention Network